Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review

References

• Abt MC, McKenney PT, Pamer EG. 2016. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 14(10):609–620.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Houghton LA, Morris J, Reilly B, Guyonnet D, Goupil Feuillerat N, Schlumberger A, Jakob S, Whorwell PJ. 2009. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 29(1):104–114.
   PubMed Web of Science ®Google Scholar
• Alemán JO, Bokulich NA, Swann JR, Walker JM, De Rosa JC, Battaglia T, Costabile A, Pechlivanis A, Liang Y, Breslow JL, et al. 2018. Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women. J Transl Med. 16(1):244.
   PubMed Web of Science ®Google Scholar
• Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, et al. 2019. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 4(9):675–685.
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M, et al. 2011. Enterotypes of the human gut microbiome. Nature. 473(7346):174–180.
   PubMed Web of Science ®Google Scholar
• Aziz I, Mumtaz S, Bholah H, Chowdhury FU, Sanders DS, Ford AC. 2015. High prevalence of idiopathic bile acid diarrhea among patients with diarrhea-predominant irritable bowel syndrome based on Rome III criteria. Clin Gastroenterol Hepatol. 13(9):1650–1655.e2.
   PubMed Web of Science ®Google Scholar
• Bajor A, Kilander A, Fae A, Gälman C, Jonsson O, Ohman L, et al. 2006. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur J Gastroenterol Hepatol. 18(4):397–403.
   PubMed Web of Science ®Google Scholar
• Bajor A, Törnblom H, Rudling M, Ung KA, Simrén M. 2015. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut. 64(1):84–92.
   PubMed Web of Science ®Google Scholar
• Barkun AN, Love J, Gould M, Pluta H, Steinhart H. 2013. Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment. Can J Gastroenterol. 27(11):653–659.
   PubMedGoogle Scholar
• Begley M, Gahan CG, Hill C. 2005. The interaction between bacteria and bile. FEMS Microbiol Rev. 29(4):625–651.
   PubMed Web of Science ®Google Scholar
• Beli E, Yan Y, Moldovan L, Vieira CP, Gao R, Duan Y, Prasad R, Bhatwadekar A, White FA, Townsend SD, et al. 2018. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice. Diabetes. 67(9):1867–1879.
   PubMed Web of Science ®Google Scholar
• Black CJ, Ford AC. 2020. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 17(8):473–486.
   PubMed Web of Science ®Google Scholar
• Borup C, Wildt S, Rumessen J, Graff J, Bouchelouche PN, Andersen TB, Vinter-Jensen L, Zaremba A, German Jørgensen SP, Gregersen T, et al. 2020. Biochemical diagnosis of bile acid diarrhea: prospective comparison with the 75seleno-taurohomocholic acid test. Am J Gastroenterol. 115(12):2086–2094.
   PubMed Web of Science ®Google Scholar
• Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon J-P, van Deventer SJH, Neirynck S, Peppelenbosch MP, Steidler L, et al. 2006. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol. 4(6):754–759.
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. 2015. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 517(7533):205–208.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Acosta A, Busciglio I, Boldingh A, Dyer RB, Zinsmeister AR, Lueke A, Gray A, Donato LJ. 2015. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 41(5):438–448.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, Burton D, Ryks M, Rhoten D, Lamsam J, Lueke A, et al. 2014. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 109(10):1621–1630.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Carlson P, Acosta A, Busciglio I. 2015. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 309(1):G10–G20.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, et al. 2014. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 307(5):G508–G516.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Vijayvargiya P. 2020. The role of bile acids in chronic diarrhea. Am J Gastroenterol. 115(10):1596–1603.
   PubMed Web of Science ®Google Scholar
• Camilleri M. 2013. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 368(6):578–579.
   PubMedGoogle Scholar
• Camilleri M. 2014. Advances in understanding of bile acid diarrhea. Expert Rev Gastroenterol Hepatol. 8(1):49–61.
   PubMed Web of Science ®Google Scholar
• Camilleri M. 2015. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 9(3):332–339.
   PubMed Web of Science ®Google Scholar
• Cao H, Xu M, Dong W, Deng B, Wang S, Zhang Y, Wang S, Luo S, Wang W, Qi Y, et al. 2017. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. Int J Cancer. 140(11):2545–2556.
   PubMed Web of Science ®Google Scholar
• Carco C, Young W, Gearry RB, Talley NJ, McNabb WC, Roy NC. 2020. Increasing evidence that irritable bowel syndrome and functional gastrointestinal disorders have a microbial pathogenesis. Front Cell Infect Microbiol. 10:468.
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. 2012. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 24(6):521–530.
   PubMed Web of Science ®Google Scholar
• Chiang JYL, Ferrell JM. 2020. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 318(3):G554–G573.
   PubMed Web of Science ®Google Scholar
• Chow MD, Lee YH, Guo GL. 2017. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mol Aspects Med. 56:34–44.
   PubMed Web of Science ®Google Scholar
• Cipriani S, Mencarelli A, Chini MG, Distrutti E, Renga B, Bifulco G, Baldelli F, Donini A, Fiorucci S. 2011. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLOS One. 6(10):e25637.
   PubMed Web of Science ®Google Scholar
• Daniel H. 2020. Diet and the gut microbiome: from hype to hypothesis. Br J Nutr. 124(6):521–530.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 505(7484):559–563.
   PubMed Web of Science ®Google Scholar
• De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, et al. 2017. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 9(379):eaaf6397.
   PubMed Web of Science ®Google Scholar
• Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. 2014. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep. 7(1):12–18.
   PubMed Web of Science ®Google Scholar
• Devkota S, Chang EB. 2015. Interactions between diet, bile acid metabolism, gut microbiota, and inflammatory bowel diseases. Dig Dis. 33(3):351–356.
   PubMed Web of Science ®Google Scholar
• Devlin AS, Fischbach MA. 2015. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol. 11(9):685–690.
   PubMed Web of Science ®Google Scholar
• Dey N, Wagner VE, Blanton LV, Cheng J, Fontana L, Haque R, Ahmed T, Gordon JI. 2015. Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell. 163(1):95–107.
   PubMed Web of Science ®Google Scholar
• Dickinson AB, Gustafsson BE, Norman A. 1971. Determination of bile acid conversion potencies of intestinal bacteria by screening in vitro and subsequent establishment in germfree rats. Acta Pathol Microbiol Scand B Microbiol Immunol. 79(5):691–698.
   PubMedGoogle Scholar
• Dior M, Delagrèverie H, Duboc H, Jouet P, Coffin B, Brot L, Humbert L, Trugnan G, Seksik P, Sokol H, et al. 2016. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome. Neurogastroenterol Motil. 28(9):1330–1340.
   PubMed Web of Science ®Google Scholar
• Dobbins JW, Binder HJ. 1976. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology. 70(6):1096–1100.
   PubMed Web of Science ®Google Scholar
• Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, et al. 2012. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 24(6):513–520.
   PubMed Web of Science ®Google Scholar
• Ducarmon QR, Zwittink RD, Hornung BVH, van Schaik W, Young VB, Kuijper EJ. 2019. Gut microbiota and colonization resistance against bacterial enteric infection. Microbiol Mol Biol Rev. 83(3):e00007-19.
   PubMed Web of Science ®Google Scholar
• Durbán A, Abellán JJ, Jiménez-Hernández N, Artacho A, Garrigues V, Ortiz V, Ponce J, Latorre A, Moya A. 2013. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome. FEMS Microbiol Ecol. 86(3):581–589.
   PubMed Web of Science ®Google Scholar
• Edenharder R, Schneider J. 1985. 12 beta-dehydrogenation of bile acids by Clostridium paraputrificum, C. tertium, and C. difficile and epimerization at carbon-12 of deoxycholic acid by cocultivation with 12 alpha-dehydrogenating Eubacterium lentum. Appl Environ Microbiol. 49(4):964–968.
   PubMed Web of Science ®Google Scholar
• Edogawa S, Edwinson AL, Peters SA, Chikkamenahalli LL, Sundt W, Graves S, Gurunathan SV, Breen-Lyles M, Johnson S, Dyer R, et al. 2020. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS. Gut. 69(1):62–73.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. 2020. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 69(5):859–867.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hausken T, Hatlebakk JG. 2019. Increasing the dose and/or repeating faecal microbiota transplantation (FMT) increases the response in patients with irritable bowel syndrome (IBS). Nutrients. 11(6):1415.
   PubMed Web of Science ®Google Scholar
• Ferrari A, Pacini N, Canzi E. 1980. A note on bile acids transformations by strains of Bifidobacterium. J Appl Bacteriol. 49(2):193–197.
   PubMedGoogle Scholar
• Fiorucci S, Distrutti E. 2015. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med. 21(11):702–714.
   PubMed Web of Science ®Google Scholar
• Flacco ME, Manzoli L, De Giorgio R, Gasbarrini A, Cicchetti A, Bravi F, Altini M, Caio GP, Ursini F. 2019. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. Eur Rev Med Pharmacol Sci. 23(7):2986–3000.
   PubMed Web of Science ®Google Scholar
• Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. 2018. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 48(10):1044–1060.
   PubMed Web of Science ®Google Scholar
• Ford AC, Sperber AD, Corsetti M, Camilleri M. 2020. Irritable bowel syndrome. Lancet. 396(10263):1675–1688.
   PubMed Web of Science ®Google Scholar
• Fu T, Coulter S, Yoshihara E, Oh TG, Fang S, Cayabyab F, Zhu Q, Zhang T, Leblanc M, Liu S, et al. 2019. FXR regulates intestinal cancer stem cell proliferation. Cell. 176(5):1098–1112.e18.
   PubMed Web of Science ®Google Scholar
• Fujisaka S, Ussar S, Clish C, Devkota S, Dreyfuss JM, Sakaguchi M, Soto M, Konishi M, Softic S, Altindis E, et al. 2016. Antibiotic effects on gut microbiota and metabolism are host dependent. J Clin Invest. 126(12):4430–4443.
   PubMed Web of Science ®Google Scholar
• Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, et al. 2018. Rebuilding the gut microbiota ecosystem. Int J Environ Res Public Health. 15(8):1679.
   Web of Science ®Google Scholar
• Ghoshal UC, Gwee KA. 2017. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol. 14(7):435–441.
   PubMed Web of Science ®Google Scholar
• Gu X, Song LJ, Li LX, Liu T, Zhang MM, Li Z, et al. 2020. Fusobacterium nucleatum causes microbial dysbiosis and exacerbates visceral hypersensitivity in a colonization-independent manner. Front Microbiol. 11:1281.
   PubMed Web of Science ®Google Scholar
• Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier C-H, Matuchansky C. 2007. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 26(3):475–486.
   PubMed Web of Science ®Google Scholar
• Hirano S, Masuda N, Oda H, Mukai H. 1981. Transformation of bile acids by Clostridium perfringens. Appl Environ Microbiol. 42(3):394–399.
   PubMed Web of Science ®Google Scholar
• Hirano S, Masuda N. 1981. Transformation of bile acids by Eubacterium lentum. Appl Environ Microbiol. 42(5):912–915.
   PubMed Web of Science ®Google Scholar
• Hirano S, Masuda N. 1982. Characterization of NADP-dependent 7 beta-hydroxysteroid dehydrogenases from Peptostreptococcus productus and Eubacterium aerofaciens. Appl Environ Microbiol. 43(5):1057–1063.
   PubMed Web of Science ®Google Scholar
• Hylemon PB, Sherrod JA. 1975. Multiple forms of 7-alpha-hydroxysteroid dehydrogenase in selected strains of Bacteroides fragilis. J Bacteriol. 122(2):418–424.
   PubMed Web of Science ®Google Scholar
• Inagaki T, Moschetta A, Lee Y-K, Peng L, Zhao G, Downes M, Yu RT, Shelton JM, Richardson JA, Repa JJ, et al. 2006. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA. 103(10):3920–3925.
   PubMed Web of Science ®Google Scholar
• Ipharraguerre IR, Pastor JJ, Gavaldà-Navarro A, Villarroya F, Mereu A. 2018. Antimicrobial promotion of pig growth is associated with tissue-specific remodeling of bile acid signature and signaling. Sci Rep. 8(1):13671.
   PubMedGoogle Scholar
• Islam KBMS, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A. 2011. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 141(5):1773–1781.
   PubMed Web of Science ®Google Scholar
• Jalanka-Tuovinen J, Salojärvi J, Salonen A, Immonen O, Garsed K, Kelly FM, Zaitoun A, Palva A, Spiller RC, de Vos WM, et al. 2014. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut. 63(11):1737–1745.
   PubMed Web of Science ®Google Scholar
• Jeffery IB, Das A, O'Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, et al. 2020. Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption. Gastroenterology. 158(4):1016–1028.e8.
   PubMed Web of Science ®Google Scholar
• Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EMM, Simrén M. 2012. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 61(7):997–1006.
   PubMed Web of Science ®Google Scholar
• Jena PK, Sheng L, Li Y, Wan YY. 2020. Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model. Hepatobiliary Surg Nutr. 9(2):170–182.
   PubMed Web of Science ®Google Scholar
• Jia B, Park D, Hahn Y, Jeon CO. 2020. Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health. Gut Microbes. 11(5):1300–1313.
   PubMed Web of Science ®Google Scholar
• Jia W, Xie G, Jia W. 2018. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 15(2):111–128.
   PubMed Web of Science ®Google Scholar
• Johnsen PH, Hilpüsch F, Valle PC, Goll R. 2020. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: secondary endpoints of a double blind, randomized, placebo-controlled trial. EBioMedicine. 51:102562.
   PubMed Web of Science ®Google Scholar
• Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. 2008. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA. 105(36):13580–13585.
   PubMed Web of Science ®Google Scholar
• Joyce SA, Gahan CG. 2017. Disease-associated changes in bile acid profiles and links to altered gut microbiota. Dig Dis. 35(3):169–177.
   PubMed Web of Science ®Google Scholar
• Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, et al. 2003. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 278(11):9435–9440.
   PubMed Web of Science ®Google Scholar
• Kim NH, Park JH, Park JS, Joung YH. 2017. The effect of deoxycholic acid on secretion and motility in the rat and guinea pig large intestine. J Neurogastroenterol Motil. 23(4):606–615.
   PubMed Web of Science ®Google Scholar
• Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA. 1975. Bile acids and colonic motility in the rabbit and the human. Gut. 16(11):894–902.
   PubMed Web of Science ®Google Scholar
• Klindt C, Reich M, Hellwig B, Stindt J, Rahnenführer J, Hengstler JG, Köhrer K, Schoonjans K, Häussinger D, Keitel V, et al. 2019. The G protein-coupled bile acid receptor TGR5 (Gpbar1) modulates endothelin-1 signaling in liver. Cells. 8(11):1467.
   PubMed Web of Science ®Google Scholar
• Kriaa A, Bourgin M, Potiron A, Mkaouar H, Jablaoui A, Gérard P, Maguin E, Rhimi M. 2019. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res. 60(2):323–332.
   PubMed Web of Science ®Google Scholar
• Kurdi P, Kawanishi K, Mizutani K, Yokota A. 2006. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol. 188(5):1979–1986.
   PubMed Web of Science ®Google Scholar
• Labus JS, Hollister EB, Jacobs J, Kirbach K, Oezguen N, Gupta A, Acosta J, Luna RA, Aagaard K, Versalovic J, et al. 2017. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome. 5(1):49.
   PubMedGoogle Scholar
• Li T, Chiang JY. 2014. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 66(4):948–983.
   PubMed Web of Science ®Google Scholar
• Li W-T, Luo Q-Q, Wang B, Chen X, Yan X-J, Qiu H-Y, Chen S-L. 2019. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis. FASEB J. 33(2):2435–2450.
   PubMed Web of Science ®Google Scholar
• Lin H, An Y, Tang H, Wang Y. 2019. Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model. J Agric Food Chem. 67(13):3624–3632.
   PubMed Web of Science ®Google Scholar
• Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT. 2017. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Dig Liver Dis. 49(4):331–337.
   PubMedGoogle Scholar
• Long SL, Gahan CGM, Joyce SA. 2017. Interactions between gut bacteria and bile in health and disease. Mol Aspects Med. 56:54–65.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Zúñiga V, Bartolí R, Planas R, Hofmann AF, Viñado B, Hagey LR, et al. 2003. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology. 37(3):551–557.
   PubMed Web of Science ®Google Scholar
• Luo L, Liu Y, Cai X, Wang Y, Xue J, Zhang J, Yang F. 2019. Bletilla striata polysaccharides ameliorates lipopolysaccharide-induced injury in intestinal epithelial cells. Saudi J Gastroenterol. 25(5):302–308.
   PubMed Web of Science ®Google Scholar
• Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC, et al. 2002. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther. 16(3):587–593.
   PubMed Web of Science ®Google Scholar
• Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M. 2016. Bowel disorders. Gastroenterology. S0016-5085(16)00222-5.
   Web of Science ®Google Scholar
• Meng C, Bai C, Brown TD, Hood LE, Tian Q. 2018. Human gut microbiota and gastrointestinal cancer. Genomics Proteomics Bioinformatics. 16(1):33–49.
   PubMed Web of Science ®Google Scholar
• Molinaro A, Wahlström A, Marschall HU. 2018. Role of bile acids in metabolic control. Trends Endocrinol Metab. 29(1):31–41.
   PubMed Web of Science ®Google Scholar
• Montagnani M, Abrahamsson A, Gälman C, Eggertsen G, Marschall H-U, Ravaioli E, Einarsson C, Dawson PA. 2006. Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. World J Gastroenterol. 12(47):7710–7714.
   PubMed Web of Science ®Google Scholar
• Mottacki N, Simrén M, Bajor A. 2016. Review article: bile acid diarrhoea – pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 43(8):884–898.
   PubMed Web of Science ®Google Scholar
• Odunsi–Shiyanbade ST, Camilleri M, McKinzie S, Burton D, Carlson P, Busciglio IA, Lamsam J, Singh R, Zinsmeister AR. 2010. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol. 8(2):159–165.
   PubMed Web of Science ®Google Scholar
• Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. 2020. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 5(10):908–917.
   PubMed Web of Science ®Google Scholar
• Paramsothy S, Nielsen S, Kamm MA, Deshpande NP, Faith JJ, Clemente JC, Paramsothy R, Walsh AJ, van den Bogaerde J, Samuel D, et al. 2019. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology. 156(5):1440–1454.e2.
   PubMed Web of Science ®Google Scholar
• Parséus A, Sommer N, Sommer F, Caesar R, Molinaro A, Ståhlman M, Greiner TU, Perkins R, Bäckhed F. 2017. Microbiota-induced obesity requires farnesoid X receptor. Gut. 66(3):429–437.
   PubMed Web of Science ®Google Scholar
• Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JYL. 2018. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. 68(4):1574–1588.
   PubMed Web of Science ®Google Scholar
• Peleman C, Camilleri M, Busciglio I, Burton D, Donato L, Zinsmeister AR. 2017. Colonic transit and bile acid synthesis or excretion in patients with irritable bowel syndrome-diarrhea without bile acid malabsorption. Clin Gastroenterol Hepatol. 15(5):720–727.e1.
   PubMed Web of Science ®Google Scholar
• Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P. 2019. Gut microbiota in patients with irritable bowel syndrome–a systematic review. Gastroenterology. 157(1):97–108.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464(7285):59–65.
   PubMed Web of Science ®Google Scholar
• Rajilić-Stojanović M, de Vos WM. 2014. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 38(5):996–1047.
   PubMed Web of Science ®Google Scholar
• Rao AS, Wong BS, Camilleri M, Odunsi-Shiyanbade ST, McKinzie S, Ryks M, Burton D, Carlson P, Lamsam J, Singh R, et al. 2010. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology. 139(5):1549–1558.e1.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Alves JM, Hylemon PB, Bajaj JS. 2013. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship. Gut Microbes. 4(5):382–387.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Bajaj JS. 2015. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharm Sin B. 5(2):99–105.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. 2016. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 7(1):22–39.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. 2014. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 30(3):332–338.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. 2006. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 47(2):241–259.
   PubMed Web of Science ®Google Scholar
• Robben J, Janssen G, Merckx R, Eyssen H. 1989. Formation of delta 2- and delta 3-cholenoic acids from bile acid 3-sulfates by a human intestinal Fusobacterium strain. Appl Environ Microbiol. 55(11):2954–2959.
   PubMed Web of Science ®Google Scholar
• Robben J, Parmentier G, Eyssen H. 1986. Isolation of a rat intestinal Clostridium strain producing 5 alpha- and 5 beta-bile salt 3 alpha-sulfatase activity. Appl Environ Microbiol. 51(1):32–38.
   PubMed Web of Science ®Google Scholar
• Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J. 2018. A review of microbiota and irritable bowel syndrome: future in therapies. Adv Ther. 35(3):289–310.
   PubMed Web of Science ®Google Scholar
• Round JL, Mazmanian SK. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA. 107(27):12204–12209.
   PubMed Web of Science ®Google Scholar
• Sadik R, Abrahamsson H, Ung KA, Stotzer PO. 2004. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol. 99(4):711–718.
   PubMed Web of Science ®Google Scholar
• Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall H-U, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F, et al. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17(2):225–235.
   PubMed Web of Science ®Google Scholar
• Shin A, Camilleri M, Vijayvargiya P, Busciglio I, Burton D, Ryks M, Rhoten D, Lueke A, Saenger A, Girtman A, et al. 2013. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 11(10):1270–1275.e1.
   PubMed Web of Science ®Google Scholar
• Song Z, Cai Y, Lao X, Wang X, Lin X, Cui Y, Kalavagunta PK, Liao J, Jin L, Shang J, et al. 2019. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome. 7(1):9.
   PubMed Web of Science ®Google Scholar
• Spencer NJ, Hu H. 2020. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 17(6):338–351.
   PubMed Web of Science ®Google Scholar
• Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, et al. 2020. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 160(1):99–114.e3.
   PubMed Web of Science ®Google Scholar
• Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. 2017. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol. 101(1):47–64.
   PubMed Web of Science ®Google Scholar
• Stotzer PO, Abrahamsson H, Bajor A, Sadik R. 2013. Effect of cholestyramine on gastrointestinal transit in patients with idiopathic bile acid diarrhea: a prospective, open-label study. Neuroenterology. 2(9):1–5.
   Google Scholar
• Sun L, Pang Y, Wang X, Wu Q, Liu H, Liu B, Liu G, Ye M, Kong W, Jiang C, et al. 2019. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. Acta Pharm Sin B. 9(4):702–710.
   PubMed Web of Science ®Google Scholar
• Sun W, Guo Y, Zhang S, Chen Z, Wu K, Liu Q, Liu K, Wen L, Wei Y, Wang B, et al. 2018. Fecal microbiota transplantation can alleviate gastrointestinal transit in rats with high-fat diet-induced obesity via regulation of serotonin biosynthesis. Biomed Res Int. 2018:8308671.
   PubMed Web of Science ®Google Scholar
• Sundin J, Rangel I, Fuentes S, Heikamp-de Jong I, Hultgren-Hörnquist E, de Vos WM, Brummer RJ. 2015. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Aliment Pharmacol Ther. 41(4):342–351.
   PubMed Web of Science ®Google Scholar
• Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M, et al. 2017. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 152(1):111–123.e8.
   PubMed Web of Science ®Google Scholar
• Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B, Huffnagle GB, Z Li J, Young VB. 2014. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 5:3114.
   PubMed Web of Science ®Google Scholar
• Ticho AL, Malhotra P, Dudeja PK, Gill RK, Alrefai WA. 2019. Intestinal absorption of bile acids in health and disease. Compr Physiol. 10(1):21–56.
   PubMed Web of Science ®Google Scholar
• Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. 2017. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol. 2(10):747–756.
   PubMed Web of Science ®Google Scholar
• Traub RJ, Tang B, Ji Y, Pandya S, Yfantis H, Sun Y. 2008. A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid. Gastroenterology. 135(6):2075–2083.
   PubMed Web of Science ®Google Scholar
• Valeur J, Småstuen MC, Knudsen T, Lied GA, Røseth AG. 2018. Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome. Dig Dis Sci. 63(2):429–436.
   PubMed Web of Science ®Google Scholar
• Van Eldere J, Mertens J, Eyssen H. 1990. Influence of intestinal bacterial desulfation on the enterohepatic circulation of dehydroepiandrosterone sulfate. J Steroid Biochem. 36(5):451–456.
   PubMedGoogle Scholar
• Van Eldere J, Robben J, De Pauw G, Merckx R, Eyssen H. 1988. Isolation and identification of intestinal steroid-desulfating bacteria from rats and humans. Appl Environ Microbiol. 54(8):2112–2117.
   PubMed Web of Science ®Google Scholar
• Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, et al. 2018. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 10(472):eaap8914.
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Chedid V, Carlson P, Busciglio I, Burton D, Donato LJ. 2019. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin Gastroenterol Hepatol. 17(5):922–929.e2.
   PubMed Web of Science ®Google Scholar
• Wahlström A, Kovatcheva-Datchary P, Ståhlman M, Khan MT, Bäckhed F, Marschall HU. 2017. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota. J Lipid Res. 58(2):412–419.
   PubMed Web of Science ®Google Scholar
• Wahlström A, Sayin SI, Marschall HU, Bäckhed F. 2016. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24(1):41–50.
   PubMed Web of Science ®Google Scholar
• Wang L, Alammar N, Singh R, Nanavati J, Song Y, Chaudhary R, Mullin GE. 2020. Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. J Acad Nutr Diet. 120(4):565–586.
   PubMed Web of Science ®Google Scholar
• Wang S, Dong W, Liu L, Xu M, Wang Y, Liu T, Zhang Y, Wang B, Cao H. 2019. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis. Mol Carcinog. 58(7):1155–1167.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao Y. 2018. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 9(5):416–431.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Fukiya S, Yokota A. 2017. Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents. J Lipid Res. 58(6):1143–1152.
   PubMed Web of Science ®Google Scholar
• Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK. 2020. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome. WJG. 26(45):7153–7172.
   PubMed Web of Science ®Google Scholar
• Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. 2014. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol. 306(4):G310–G319.
   PubMed Web of Science ®Google Scholar
• Weingarden AR, Dosa PI, DeWinter E, Steer CJ, Shaughnessy MK, Johnson JR, Khoruts A, Sadowsky MJ. 2016. Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth. PLOS One. 11(1):e0147210.
   PubMed Web of Science ®Google Scholar
• Wingate DL, Krag E, Mekhjian HS, Phillips SF. 1973. Relationships between ion and water movement in the human jejunum, ileum and colon during perfusion with bile acids. Clin Sci Mol Med. 45(5):593–606.
   PubMedGoogle Scholar
• Winston JA, Theriot CM. 2020. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 11(2):158–171.
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson PJ, Odunsi-Shiyanbade S, McKinzie S, Busciglio I, Burton D, Zinsmeister AR. 2012. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci. 57(5):1222–1226.
   PubMed Web of Science ®Google Scholar
• Wu KQ, Sun WJ, Li N, Chen YQ, Wei YL, Chen DF. 2019. Small intestinal bacterial overgrowth is associated with diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. Scand J Gastroenterol. 54(12):1419–1425.
   PubMed Web of Science ®Google Scholar
• Yang T, Shu T, Liu G, Mei H, Zhu X, Huang X, Zhang L, Jiang Z. 2017. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids. J Steroid Biochem Mol Biol. 172:69–78.
   PubMed Web of Science ®Google Scholar
• Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY, et al. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 161(2):264–276.
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al. 2013. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 499(7456):97–101.
   PubMed Web of Science ®Google Scholar
• Zhao L, Yang W, Chen Y, Huang F, Lu L, Lin C, Huang T, Ning Z, Zhai L, Zhong LL, et al. 2020. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J Clin Invest. 130(1):438–450.
   PubMed Web of Science ®Google Scholar
• Zheng X, Huang F, Zhao A, Lei S, Zhang Y, Xie G, Chen T, Qu C, Rajani C, Dong B, et al. 2017. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice. BMC Biol. 15(1):120.
   PubMedGoogle Scholar
• Zuo T, Kamm MA, Colombel JF, Ng SC. 2018. Urbanization and the gut microbiota in health and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 15(7):440–452.
   PubMed Web of Science ®Google Scholar